Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015 (2015), Article ID 158361, 10 pages
http://dx.doi.org/10.1155/2015/158361
Research Article

Zuogui Jiangtang Jieyu Formulation Prevents Hyperglycaemia and Depressive-Like Behaviour in Rats by Reducing the Glucocorticoid Level in Plasma and Hippocampus

1Hunan University of Chinese Medicine, No. 300, Bachelor Road, Changsha, Hunan 410208, China
2First Hospital of Hunan University of Chinese Medicine, Hunan, China

Received 30 September 2014; Revised 8 January 2015; Accepted 9 January 2015

Academic Editor: Kazuo Toda

Copyright © 2015 YuHong Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. International Diabetes Federation, (1950–2014), 2014, http://www.idf.org/about-diabetes.
  2. T. Wu, G. Xie, Y. Ni et al., “Serum metabolite signatures of type 2 diabetes mellitus complications,” Journal of Proteome Research. In press.
  3. D. Selvarajah and S. Tesfaye, “Central nevous system involvement in diabetes mellitus,” Current Diabetes Reports, vol. 6, no. 6, pp. 431–438, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Sartorius and L. Cimino, “The co-occurrence of diabetes and depression: an example of the worldwide epidemic of comorbidity of mental and physical illness,” Annals of the Academy of Medicine Singapore, vol. 41, no. 10, pp. 430–431, 2012. View at Google Scholar · View at Scopus
  5. L. E. Egede and C. Ellis, “Diabetes and depression: global perspectives,” Diabetes Research and Clinical Practice, vol. 87, no. 3, pp. 302–312, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. Y.-H. Wang, L.-T. Yin, H. Yang, X.-L. Li, and K.-G. Wu, “Hypoglycemic and anti-depressant effects of Zuogui Jiangtang Jieyu formulation in a model of unpredictable chronic mild stress in rats with diabetes mellitus,” Experimental and Therapeutic Medicine, vol. 8, no. 1, pp. 281–285, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. S. M. Gold, I. Dziobek, V. Sweat et al., “Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes,” Diabetologia, vol. 50, no. 4, pp. 711–719, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. I. Sheline, “Depression and the hippocampus: cause or effect?” Biological Psychiatry, vol. 70, no. 4, pp. 308–309, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Agyemang, L. Han, E. Liu, Y. Zhang, T. Wang, and X. Gao, “Recent advances in astragalus membranaceus anti-diabetic research: pharmacological effects of its phytochemical constituents,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 654643, 9 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. C. H. Park, J. S. Noh, T. Tanaka, S. S. Roh, J. C. Lee, and T. Yokozawa, “Polyphenol isolated from Corni Fructus, 7-O-galloyl-d-sedoheptulose, modulates advanced glycation endproduct-related pathway in type 2 diabetic db/db mice,” Archives of Pharmacal Research, 2014. View at Publisher · View at Google Scholar
  11. F. Z. Talukder, K. A. Khan, R. Uddin, N. Jahan, and M. A. Alam, “In vitro free radical scavenging and anti-hyperglycemic activities of Achyranthes aspera extract in alloxan-induced diabetic mice,” Drug Discoveries & Therapeutics, vol. 6, no. 6, pp. 298–305, 2012. View at Publisher · View at Google Scholar
  12. L. Zhang, J. Luo, M. Zhang, W. Yao, X. Ma, and S. Y. Yu, “Effects of curcumin on chronic, unpredictable, mild, stress-induced depressive-like behaviour and structural plasticity in the lateral amygdala of rats,” International Journal of Neuropsychopharmacology, vol. 17, no. 5, pp. 793–806, 2014. View at Publisher · View at Google Scholar
  13. J. Tian, F. Zhang, J. Cheng, S. Guo, P. Liu, and H. Wang, “Antidepressant-like activity of adhyperforin, a novel constituent of Hypericum perforatum L,” Scientific Report, vol. 9, no. 4, article 5632, 2014. View at Publisher · View at Google Scholar
  14. L. An, Y.-Z. Zhang, X.-M. Liu et al., “Total flavonoids extracted from xiaobuxin-tang on the hyperactivity of hypothalamic-pituitary-adrenal axis in chronically stressed rats,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 367619, 7 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. B. Budziszewska, “Effect of antidepressant drugs on the hypothalamic-pituitary-adrenal axis activity and glucocorticoid receptor function,” Polish Journal of Pharmacology, vol. 54, no. 4, pp. 343–349, 2002. View at Google Scholar · View at Scopus
  16. V. Butterweck, M. Hegger, and H. Winterhoff, “Flavonoids of St. John's Wort reduce HPA axis function in the rat,” Planta Medica, vol. 70, no. 10, pp. 1008–1011, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Willner, “Chronic Mild Stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS,” Neuropsychobiology, vol. 52, no. 2, pp. 90–110, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Thieringer and A. Hermanowski-Vosatka, “Inhibition of 11β-HSD1 as a novel treatment for the metabolic syndrome: do glucocorticoids play a role?” Expert Review of Cardiovascular Therapy, vol. 3, no. 5, pp. 911–924, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. J. R. Seckl and B. R. Walker, “Minireview: 11β-hydroxysteroid dehydrogenase type 1—a tissue-specific amplifier of glucocorticoid action,” Endocrinology, vol. 142, no. 4, pp. 1371–1376, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. J. Liu, Y. Nakagawa, Y. Wang et al., “Increased glucocorticqid receptor and 11β-hydroxysteroid dehydrogenase type 1 expression in hepatocytes may contribute to the phenotype of type 2 diabetes in db/db mice,” Diabetes, vol. 54, no. 1, pp. 32–40, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Draper and P. M. Stewart, “11β-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action,” Journal of Endocrinology, vol. 186, no. 2, pp. 251–271, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. R. A. S. Schweizer, A. G. Atanasov, B. M. Frey, and A. Odermatt, “A rapid screening assay for inhibitors of 11β-hydroxysteroid dehydrogenases (11β-HSD): flavanone selectively inhibits 11β-HSD1 reductase activity,” Molecular and Cellular Endocrinology, vol. 212, no. 1-2, pp. 41–49, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. J. L. W. Yau, T. Olsson, R. G. M. Morris, M. J. Meaney, and J. R. Seckl, “Glucocorticoids, hippocampal corticosteroid receptor gene expression and antidepressant treatment: relationship with spatial learning in young and aged rats,” Neuroscience, vol. 66, no. 3, pp. 571–581, 1995. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Beauquis, P. Roig, F. Homo-Delarche, A. de Nicola, and F. Saravia, “Reduced hippocampal neurogenesis and number of hilar neurones in streptozotocin-induced diabetic mice: reversion by antidepressant treatment,” European Journal of Neuroscience, vol. 23, no. 6, pp. 1539–1546, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. W. Katon, J. Unützer, M.-Y. Fan et al., “Cost-effectiveness and net benefit of enhanced treatment of depression for older adults with diabetes and depression,” Diabetes Care, vol. 29, no. 2, pp. 265–270, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Thomson and M. Craighead, “Innovative approaches for the treatment of depression: targeting the HPA axis,” Neurochemical Research, vol. 33, no. 4, pp. 691–707, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. L. An, Y.-Z. Zhang, X.-M. Liu et al., “Total flavonoids extracted from Xiaobuxin-Tang on the hyperactivity of hypothalamic-pituitary-adrenal axis in chronically stressed rats,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 367619, 7 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. P. J. Lustman and R. E. Clouse, “Treatment of depression in diabetes: impact on mood and medical outcome,” Journal of Psychosomatic Research, vol. 53, no. 4, pp. 917–924, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. J. C. Fournier, R. J. DeRubeis, S. D. Hollon et al., “Antidepressant drug effects and depression severity: a patient-level meta-analysis,” The Journal of the American Medical Association, vol. 303, no. 1, pp. 47–53, 2010. View at Publisher · View at Google Scholar · View at Scopus